Cell Penetrating Peptide Market To Reach $2.85 Billion By 2030

Cell Penetrating Peptide Market Growth & Trends

The global cell penetrating peptide market size is expected to reach USD 2.85 billion by 2030, expandingat a CAGR of 10.08% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing demand for targeted drug delivery methods is the primary factor propelling the growth. Technological advancements in chemical modification strategies & peptide synthesis techniques and increasing R&D activities to introduce precise therapeutics are increasing the demand for cell penetrating peptides in the market.

Moreover, rising approvals of novel drugs based on CPP technology is expected to offer lucrative opportunities for the key players during the study period. For instance, in September 2022, Revance Therapeutics, Inc. received U.S. Food and Drug Administration approval for DAXXIFY, which is developed based on cell-penetrating technology for temporary improvement of severe to moderate frown lines. This approval is projected to boost the market growth.

Advancements in the production processes of peptides are expected to drive the market. Manufacturers and suppliers are focused on developing new methods for synthesizing peptides, such as cell penetrating peptides. Improvement and automation of the purification process and lower waste generation are further increasing the demand for CPPs in different applications. For instance, in March 2022, Creative Peptides introduced innovative peptide drug discovery services to speed the development of peptide therapeutics, including CPPs therapies.

Growing funding for developing novel drugs to treat numerous diseases using cell penetrating peptides is anticipated to open new avenues for the market stakeholders. For instance, in September 2022, the Keck Graduate Institute received a research grant of USD 500,000 from the Foundation for Angelman Syndrome Therapeutics for two years to support research activities related to CPPs to targetAngelman Syndrome. Such initiatives are boosting the cell penetrating peptide sector growth.

However, cell penetrating peptides can certainly be synthesized on solid support using manual methods, and these can be tedious and time-intensive. The equipment for new systems can cost from USD 30,000 to USD 200,000 and above, depending on the synthesis scale capability & software. Hence, the high cost of manufacturing equipment may hamper the development of cell penetrating peptides by small players and emerging economies. On the other hand, continuous technological advancements are likely to boost the applications of CPPs during the forecast period.

 Request a free sample copy or view report summary: Cell Penetrating Peptide Market Report

Cell Penetrating Peptide Market Report Highlights

• Based on type, the synthetic CPPs segment dominated the market in 2023 owing to their intrinsic property of delivering therapeutic molecules such as drugs, imaging agents, and nucleic acids

• Based on application, the drug delivery segment held the largest segment share of the market in 2023, attributable to their low toxicity and efficiency of drug delivery into target cells

• Based on end-use, the pharmaceutical & biotechnology companies segment led the market in 2023. It can be attributed to the rising utilization of peptides in pharmaceutical and biotechnology companies for R&D activities and the production of novel diagnostics and therapeutics

• North America has established a strong regional position with a highest market share owing to the increasing funding for cell penetrating peptide research, favorable government policies, technological advancements, and the presence of key operating players in the region

Cell Penetrating Peptide Market Segmentation

For this report, Grand View Research has segmented the global cell penetrating peptide market based on type, application, end-use, and region:

Cell Penetrating Peptide Type Outlook (Revenue, USD Million, 2018 - 2030)

• Protein-derived CPPs

• Synthetic CPPs

• Chimeric CPPs

Cell Penetrating Peptide Application Outlook (Revenue, USD Million, 2018 - 2030)

• Drug Delivery

• Gene Delivery

• Diagnostics

• Molecular Imaging

• Others

Cell Penetrating Peptide End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical and Biotechnology Companies

• Contract Research Organization (CROs)

• Hospitals and Clinics

• Others

Cell Penetrating Peptide Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Cell Penetrating Peptide Market

• Pepscan

• Creative Peptides

• Cupidpeptides

• AltaBioscience Ltd

• AnaSpec

• Peptomyc

• BioAlps

• Sarepta Therapeutics, Inc.

• REVANCE THERAPEUTICS

• PolyPeptide Group

• Bachem